suggested that inhibiting O-GlcNAcylation of phosphoenolpyruvate carboxykinase 1 (PCK1) at threonine 255 reduces colon cancer cell proliferation, decreased glycolysis, incerased tricarboxylic acid cycle activity, and inhibitd tumor growth in xenograft models. This evidence concerns the gene PCK1 and malignant colon neoplasm.